Comparing doses of cholesterol medicine for stroke with brain microbleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a more intensive dose of a common cholesterol medicine (atorvastatin) increases or decreases the risk of bleeding in the brain for people who have had a stroke and also have tiny brain bleeds. It aims to find the safest and most effective way to use statins in this situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 85 years old and have had an ischemic stroke in the past 14 days.
- Your brain MRI must show tiny areas of bleeding called cerebral microbleeds.
- Your stroke should be mild or moderate, not severe, and you must not be in a coma.
- You must not have had any bleeding in the brain in the past 6 months.
- You cannot have active liver disease or certain muscle problems.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This trial tests if the statin drug atorvastatin can help people recover from a type of stroke called a brain bleed. It is for adults who have a moderate-sized bleed in the upper part of the brain and can start taking the drug within 48 hours of symptoms.
This trial tests whether a higher-dose statin can help after an ischemic stroke in people who have specific plaque patterns in brain blood vessels. It may help lower the risk of another stroke by targeting the artery plaque process.
This study tests if combining the blood thinner clopidogrel with either atorvastatin or rosuvastatin (both cholesterol-lowering drugs) works better for people who have had a mild first-time stroke in the small blood vessels of the brain. The goal is to find a safe and effective treatment regimen.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.